Trident Texofab Ltd — Important, 10-08-2026: Company Update

Trident Texofab has announced a board meeting where it approved the financial results for the quarter, reporting Revenue from Operations of 26.14 Cr and a profit of 0.52 Cr. The company also accepted the resignation of its Statutory Auditor, Shah Kailash and Associates LLP, and appointed Prit Agrawal & Co. as the Internal Auditor for FY 2026-27. Separately, the company forfeited 25% of the amount received for 9,11,479 warrants due to the expiry of their conversion period. This addresses financial performance and key governance changes impacting shareholder transparency and compliance.